• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Sertraline is associated with a lower risk of opioid overdose compared to other selective serotonin reuptake inhibitors in patients taking hydrocodone

byPaary BalakumarandSimon Pan
January 13, 2026
in Chronic Disease, Pharma, Psychiatry
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Sertraline appears to be the safest selective serotonin reuptake inhibitor (SSRI) option for patients taking hydrocodone because it is associated with a lower risk of opioid overdose than other selective serotonin reuptake inhibitors.

Evidence Rating Level: 2 (Good) 

Hydrocodone is widely prescribed for pain and is often co-prescribed with selective serotonin reuptake inhibitors (SSRIs), raising concern for pharmacokinetic and pharmacodynamic interactions that may increase overdose risk. This target-trial emulated, population-based cohort study used four United States claims databases (2004–2022) to identify 1.49 million adults receiving hydrocodone who initiated sertraline, citalopram, escitalopram, fluoxetine, or paroxetine. Opioid overdose leading to hospitalization or emergency department visit was ascertained using validated diagnosis codes. Propensity score matching weights balanced 168 baseline covariates, and weighted Cox models estimated pairwise hazard ratios in on-treatment and 60-day intention-to-treat analyses. Over a median 28-day on-treatment follow-up, 1500 overdoses occurred; weighted incidence was 6.1 per 1000 person-years for sertraline versus 7.2–7.9 for other SSRIs. Compared with sertraline, overdose risk was higher with citalopram, escitalopram, fluoxetine, and paroxetine (hazard ratios 1.17–1.29), while risks were similar across non-sertraline SSRIs. Sensitivity and subgroup analyses, including alternate overdose definitions and high-risk strata (other opioid use, substance use disorders, concomitant central nervous system depressants), were consistent with the primary findings.

Click here to read this study in BMC Medicine

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Middle-aged and older Canadians at high risk of obstructive sleep apnea may have worse mental health outcomes

2 Minute Medicine Rewind December 29th, 2025

Higher dose extended-release buprenorphine may reduce opioid use in patients with heavy fentanyl use

Tags: hydrocodoneopioid overdosepsychiatrysertralineSSRI
Previous Post

Cardiac arrhythmias may be common among hospitalized adults with COVID-19 and no structural heart disease

Next Post

Short-course personalized acoustic therapy may increase tinnitus remission in patients with idiopathic sudden sensorineural hearing loss

RelatedReports

Admission may not be needed following sleep apnea surgery
Chronic Disease

Middle-aged and older Canadians at high risk of obstructive sleep apnea may have worse mental health outcomes

January 12, 2026
Admission may not be needed following sleep apnea surgery
Weekly Rewinds

2 Minute Medicine Rewind December 29th, 2025

January 12, 2026
Patients with low back pain or pain at multiple sites at highest risk for chronic opioid use
Chronic Disease

Higher dose extended-release buprenorphine may reduce opioid use in patients with heavy fentanyl use

January 13, 2026
AAP continues to recommend fluoride for prevention of dental caries
Weekly Rewinds

2MM Rewind December 8th, 2025

January 13, 2026
Next Post
Bilateral diagonal earlobe creases associated with increased risk of coronary artery disease

Short-course personalized acoustic therapy may increase tinnitus remission in patients with idiopathic sudden sensorineural hearing loss

AAP continues to recommend fluoride for prevention of dental caries

2MM Rewind December 8th, 2025

Lisinopril and carvedilol reduce cardiotoxicity in breast cancer patients receiving trastuzumab and anthracyclines

A biomarker-guided approach to cardioprotection in cancer patients receiving anthracyclines is associated with improvements in left ventricular ejection fraction

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Ethosuximide may not be effective for the treatment of abdominal pain in irritable bowel syndrome
  • Edaravone dexborneol improves functional independence in patients with acute ischaemic stroke following endovascular thrombectomy
  • Yartemlea (narsoplimab-wuug) improves platelets hemolysis organ function hematopoietic stem cell transplant–associated thrombotic microangiopathy transplant patients
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.